
In this CME, review novel, currently available, and promising pharmacological treatment options for treatment-resistant depression.
Dr Park is the medical director of the clinical research unit in the experimental therapeutics and pathophysiology branch at the National Institute of Mental Health.
In this CME, review novel, currently available, and promising pharmacological treatment options for treatment-resistant depression.
Published: May 6th 2022 | Updated: